BackTopchoice Medical Overview

Topchoice Medical EBIT

Topchoice Medical's EBIT is $830M, below the sector sector average of $2.4T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$304.43M
↑ 14.84% YoY

As of Sep 30, 2026

Annual EBIT (TTM)

$830.45M
↑ 18.32% YoY

Trailing 12 months ending Sep 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Topchoice Medical (600763.SS) FAQ

The latest EBIT for 600763.SS is $830M as of September 2026. That compares with $700M in the prior-year period — up 18.3% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside Topchoice Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, 600763.SS's EBIT moved from $700M to $830M — a 18.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Topchoice Medical's operating scale or balance-sheet position.

Against its sector companies, 600763.SS currently prints $830M for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Topchoice Medical's growth, margins, and balance sheet.

A EBIT figure of $830M for 600763.SS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting 600763.SS's EBIT ($830M), review year-over-year change from $700M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.